Leo A. van Grunsven

15.0k citations

148 papers · 7.3k indexed · 1 hit paper · h-index 46

Molecular Biology top 2%
Hepatology top 0.2%
Epidemiology top 1%
Oncology top 2%
Surgery top 2%

Co-authors: Inge Mannaerts Danny Huylebroeck Kristin Verschueren Geert Berx Frans van Roy Erik Bruyneel Petra Vermassen Étienne Sokal
Topics: Liver physiology and pathology (72 papers)Liver Disease Diagnosis and Treatment (51 papers)Organ Transplantation Techniques and Outcomes (20 papers)
Cited by: Hepatology Cancer Research Cell Biology
Journals: Science Journal of Biological Chemistry Journal of Neuroscience
Partner nations: Belgium Germany United Kingdom

In The Last Decade

Leo A. van Grunsven

143 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion

2001 1.1k citations Kristin Verschueren, Leo A. van Grunsven et al. profile →

Peers

Countries citing papers authored by Leo A. van Grunsven

Since Specialization

Citations

This map shows the geographic impact of Leo A. van Grunsven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo A. van Grunsven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo A. van Grunsven more than expected).

Fields of papers citing papers by Leo A. van Grunsven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo A. van Grunsven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo A. van Grunsven. The network helps show where Leo A. van Grunsven may publish in the future.

Co-authorship network of co-authors of Leo A. van Grunsven

This figure shows the co-authorship network connecting the top 25 collaborators of Leo A. van Grunsven. A scholar is included among the top collaborators of Leo A. van Grunsven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo A. van Grunsven. Leo A. van Grunsven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation 2025 ·Journal of Hepatology ·(unknown),Hans Mol,(unknown),Weronika Kowalczyk,Leticia Sansores-García,(unknown),Hanne Hillen,Leen Van Huffel,Matthias Van Haele,(unknown),(unknown),Leo A. van Grunsven,Tania Roskams,Olivier Govaere,Iván M. Moya,Georg Halder	1
2	Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF‐κВ and WNT Signaling 2023 ·Advanced Science ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Ruben Boon,Joris Vriens,Leo A. van Grunsven,Kian Peng Koh,Catherine M. Verfaillie,Frederic Lluı́s	5
3	Spatially Self‐Organized Three‐Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development 2023 ·Advanced Science ·Yoke Chin Chai,San Kit To,(unknown),Samantha Zaunz,Yingli Zhu,Karan Ahuja,(unknown),(unknown),(unknown),Keimpe Wierda,Stefaan Verhulst,Leo A. van Grunsven,Vincent Pasque,Catherine M. Verfaillie	8
4	Hippo signaling instructs ectopic but not normal organ growth 2022 ·Science ·Weronika Kowalczyk,(unknown),Mardelle Atkins,Hanne Hillen,Carmen Bravo González‐Blas,Jelle Jacobs,Jun Xie,(unknown),Elisabeth Verboven,Iván M. Moya,Stefaan Verhulst,Maxime De Waegeneer,Leticia Sansores-García,Leen Van Huffel,Randy L. Johnson,Leo A. van Grunsven,Stein Aerts,Georg Halder	43
5	PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells 2021 ·Cell Death and Disease ·Jonathan De Smedt,(unknown),Irene Talón,(unknown),Burak Toprakhisar,Rodrigo Madeiro da Costa,Samantha Zaunz,(unknown),Ruben Boon,Pieter Baatsen,Ayla Smout,Stefaan Verhulst,Leo A. van Grunsven,Catherine M. Verfaillie	29
6	A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model 2021 ·Biomaterials ·Manoj Kumar,Burak Toprakhisar,Matthias Van Haele,Asier Antoranz,Ruben Boon,(unknown),Jonathan De Smedt,Tine Tricot,(unknown),(unknown),(unknown),(unknown),(unknown),Adrian Ranga,Francesca M. Bosisio,Tania Roskams,Leo A. van Grunsven,Catherine M. Verfaillie	26
7	Initiation of hepatic stellate cell activation extends into chronic liver disease 2021 ·Cell Death and Disease ·Vincent De Smet,Nathalie Eysackers,(unknown),(unknown),Georg Halder,Stefaan Verhulst,Inge Mannaerts,Leo A. van Grunsven	46
8	Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers 2019 ·Cells ·(unknown),Elisabeth Verboven,Leen Van Huffel,Iván M. Moya,Leo A. van Grunsven,Isabelle Leclercq,Frédéric P. Lemaigre,Georg Halder	12
9	Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury 2019 ·Journal of Hepatology ·Rita Manco,Laure‐Alix Clerbaux,Stefaan Verhulst,(unknown),Christine Sempoux,Jérôme Ambroise,Bertrand Bearzatto,(unknown),Yves Horsmans,Leo A. van Grunsven,Chantal Desdouets,Isabelle Leclercq	64
10	Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression 2017 ·Cancer Research ·Eva De Smedt,Ken Maes,Stefaan Verhulst,Hui Lui,Alboukadel Kassambara,Anke Maes,Nicolas Robert,Carlo Heirman,Andrew Cakana,Dirk Hose,Karine Breckpot,Leo A. van Grunsven,Kim De Veirman,Eline Menu,Karin Vanderkerken,Jérôme Moreaux,Elke De Bruyne	30
11	Isolation and Characterization of Bone Marrow Mesenchymal Stromal Cell Subsets in Culture Based on Aldehyde Dehydrogenase Activity 2017 ·Tissue Engineering Part C Methods ·Mehdi Najar,Laurent Dollé,Emerence Crompot,Stefaan Verhulst,Leo A. van Grunsven,(unknown),Laurence Lagneaux	4
12	Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Joost Willebrords,Michaël Maes,Isabel Veloso Alves Pereira,Tereza Cristina da Silva,(unknown),(unknown),Sara Crespo Yanguas,Valery I. Shestopalov,Marina Sayuri Nogueira,Inar Alves de Castro,Anwar Farhood,Inge Mannaerts,Leo A. van Grunsven,Jephte Y. Akakpo,Margitta Lebofsky,Hartmut Jaeschke,Bruno Cogliati,Mathieu Vinken	23
13	Human hepatic stellate cells and inflammation: A regulated cytokine network balance 2016 ·Cytokine ·Mehdi Najar,Hussein Fayyad‐Kazan,Wissam H. Faour,Adil El Taghdouini,Gordana Raicevic,Mustapha Najimi,Michel Toungouz,Leo A. van Grunsven,Étienne Sokal,Laurence Lagneaux	11
14	In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes 2013 ·Biomaterials ·(unknown),Tom Struys,Tom Dresselaers,Michael Hodenius,Inge Mannaerts,Yicheng Ni,Ivo Lambrichts,Leo A. van Grunsven,Marcel De Cuyper,Uwe Himmelreich	23
15	Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis 2013 ·Toxicology and Applied Pharmacology ·Katrien Van Beneden,Caroline Geers,Marina Pauwels,Inge Mannaerts,Karl Martin Wissing,Christiane Van Den Branden,Leo A. van Grunsven	52
16	Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology 2009 ·Journal of Cellular and Molecular Medicine ·Joanna Fraczek,Leo A. van Grunsven,Mathieu Vinken,(unknown),(unknown),Karin Vanderkerken,Tamara Vanhaecke,Vera Rogiers	16
17	CTLA‐4 interacts with STAT5 and inhibits STAT5‐mediated transcription 2005 ·Immunology ·Mohammed Srahna,Leo A. van Grunsven,Jacques Remacle,Peter Vandenberghe	10
18	Smicl is a novel Smad interacting protein and cleavage and polyadenylation specificity factor associated protein 2005 ·Genes to Cells ·Clara Collart,Jacques Remacle,Silvia M.L. Barabino,Leo A. van Grunsven,L Nelles,Ann Schellens,Tom Van de Putte,Stefan Pype,Danny Huylebroeck,Kristin Verschueren	12
19	Dynamic regulation of Brachyury expression in the amphibian embryo by XSIP1 2002 ·Mechanisms of Development ·Catherine Papin,Leo A. van Grunsven,Kristin Verschueren,Danny Huylebroeck,James C. Smith	37
20	Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations 1997 ·Oncogene ·Mireille Rossel,Andrea Pasini,(unknown),(unknown),(unknown),Isabelle Schuffenecker,(unknown),Leo A. van Grunsven,José Luis Urdiales,Brian B. Rudkin,Gilbert Lenoir,Marc Billaud	84

About Leo A. van Grunsven

Leo A. van Grunsven is a scholar working on Hepatology, Epidemiology and Cell Biology, having authored 148 papers that have together received 7.3k indexed citations. Recurring topics across this work include Liver physiology and pathology (72 papers), Liver Disease Diagnosis and Treatment (51 papers) and Organ Transplantation Techniques and Outcomes (20 papers). The work is most often cited by research in Hepatology (2.1k citations), Cancer Research (933 citations) and Cell Biology (882 citations). Leo A. van Grunsven has collaborated with scholars based in Belgium, Germany and United Kingdom. Frequent co-authors include Inge Mannaerts, Danny Huylebroeck, Kristin Verschueren, Geert Berx, Frans van Roy, Erik Bruyneel, Petra Vermassen, Étienne Sokal, Marc Mareel and Mustapha Najimi. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact